Average Co-Inventor Count = 6.63
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Immatics Biotechnologies Gmbh (150 from 725 patents)
2. Immatics Us, Inc. (9 patents)
152 patents:
1. 12318407 - Peptides displayed by HLA for use in immunotherapy against different types of cancers
2. 12290530 - Peptides displayed by HLA for use in immunotherapy against different types of cancers
3. 12285443 - Peptides displayed by HLA for use immunotherapy against different types of cancers
4. 12274716 - Peptides displayed by HLA for use immunotherapy against different types of cancers
5. 12269881 - Antigen binding proteins specifically binding MAGE-A
6. 12257269 - Peptides displayed by HLA for use in immunotherapy against different types of cancers
7. 12246039 - Peptides displayed by HLA for use in immunotherapy against different types of cancers
8. 12227556 - Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods
9. 12202878 - Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
10. 12195506 - Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods
11. 12195516 - Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
12. 12162917 - B*44 restricted peptides for use in immunotherapy against cancers and related methods
13. 12098183 - Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
14. 12084486 - Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
15. 12076379 - A*03 restricted peptides for use in immunotherapy against cancers and related methods